000 01409 a2200397 4500
005 20250515052922.0
264 0 _c20070515
008 200705s 0 0 eng d
022 _a0960-894X
024 7 _a10.1016/j.bmcl.2006.12.020
_2doi
040 _aNLM
_beng
_cNLM
100 1 _aGilbert, Adam M
245 0 0 _a5-((1H-pyrazol-4-yl)methylene)-2-thioxothiazolidin-4-one inhibitors of ADAMTS-5.
_h[electronic resource]
260 _bBioorganic & medicinal chemistry letters
_cMar 2007
300 _a1189-92 p.
_bdigital
500 _aPublication Type: Journal Article
650 0 4 _aADAM Proteins
_xantagonists & inhibitors
650 0 4 _aADAMTS4 Protein
650 0 4 _aADAMTS5 Protein
650 0 4 _aAggrecans
_xdrug effects
650 0 4 _aCartilage
650 0 4 _aHumans
650 0 4 _aInhibitory Concentration 50
650 0 4 _aOsteoporosis
_xdrug therapy
650 0 4 _aProcollagen N-Endopeptidase
650 0 4 _aStructure-Activity Relationship
650 0 4 _aThiazolidinediones
_xchemical synthesis
700 1 _aBursavich, Matthew G
700 1 _aLombardi, Sabrina
700 1 _aGeorgiadis, Katy E
700 1 _aReifenberg, Erica
700 1 _aFlannery, Carl R
700 1 _aMorris, Elisabeth A
773 0 _tBioorganic & medicinal chemistry letters
_gvol. 17
_gno. 5
_gp. 1189-92
856 4 0 _uhttps://doi.org/10.1016/j.bmcl.2006.12.020
_zAvailable from publisher's website
999 _c16776115
_d16776115